Mawi DNA Technologies

Executive Summary

Mawi DNA Technologies is a private company headquartered in Hayward, California, founded in 2013. It specializes in non-invasive biosample collection through its proprietary iSWAB® technology platform, which enables ambient-temperature stabilization and transport of DNA and RNA from various sample types. The company's mission is to simplify genomics and proteomics workflows by ensuring sample integrity from collection to analysis, regardless of location. Mawi's products are used in diagnostics, research, and population health, offering a cost-effective and user-friendly alternative to traditional collection methods. While the company has not disclosed funding or valuation, its innovative platform has positioned it as a key player in the biosampling market, with potential applications in liquid biopsy, companion diagnostics, and direct-to-consumer testing. The executive summary highlights Mawi's focus on enabling decentralized sample collection, which aligns with the growing trend toward remote healthcare and personalized medicine.

Upcoming Catalysts (preview)

• Q3 2026FDA clearance or CE marking for a new diagnostic application using iSWAB40% success
• Q4 2026Strategic partnership with a major pharma or diagnostic company for clinical trial sample collection50% success
• Q2 2027Launch of a direct-to-consumer genetic testing kit leveraging iSWAB technology30% success